

Zafgen, a biopharmaceutical company, develops obesity therapeutics that help the body regain and sustain a lean and healthy state. Among its major competitors, Zafgen is ranked in 5th place for NPS while Novo Nordisk is 1st, and Eli Lilly and Company is 2nd.Their current market cap is $37.10M